Association of Left Atrial Size with Atrial Fibrillation in Rheumatic Mitral Stenosis
DOI:
https://doi.org/10.51253/pafmj.v75iSUPPL-3.12777Keywords:
Atrial Fibrillation, Left Atrial Size, Rheumatic Mitral Stenosis.Abstract
Objective: To determine the association of Left Atrial (LA) size with atrial fibrillation (AF) in patients with Rheumatic Mitral Stenosis.
Study Design: Analytical Cross-sectional study.
Place and Duration of Study: Adult Cardiology Department, Armed Force Institute of Cardiology/National Institute of Heart Diseases, Rawalpindi Pakistan, from Aug 2023 to Mar 2024.
Methodology: One hundred and twenty-eight patients with an age range of 20-60 years who were diagnosed with rheumatic mitral stenosis based on echo findings were included via consecutive sampling technique. Left atrium size, mitral valve area, and left ventricular ejection fraction were measured with a transthoracic echocardiogram (TTE) to assess the severity of stenosis and the risk of atrial fibrillation.
Results: Out of 128 study participants, 73(57.0%) were females, whereas 55(42.3%) were males and mean age was 44.52±11.88 years. The median size of the left atrium and mitral valve area was 47.00(42.00-51.00) mm and 1.04(0.83-1.30) cm2 respectively. Atrial Fibrillation was reported in 86(67.2%) patients, and majority of them 85(98.8%) had LA size >40mm, while 26(61.9%) out of 42 patients with no AF had LA size >40mm (p<0.001). Patients with AF also showed lower median ejection fraction (55.00% vs 60.00%) and higher mean values of age and median LA size (47.25±10.22 vs 38.92±13.17 years; 49.00mm vs 42.00mm respectively) compared to those who had no AF (p<0.01).
Conclusion: Left atrial enlargement is significantly associated with development of atrial fibrillation in patients with rheumatic mitral stenosis.
Downloads
References
Auala T, Zavale BG, Mbakwem AÇ, Mocumbi AO. Acute rheumatic fever and rheumatic heart disease: Highlighting the role of group A Streptococcus in the global burden of cardiovascular disease. Pathogens 2022; 11(5): 496.
http://dx.doi.org/10.3390/pathogens11050496
Antunes MJ. The global burden of rheumatic heart disease: population-related differences (it is not all the same!). Braz J Cardiovasc Surg 2020; 35: 958-963.
https://doi.org/10.21470/1678-9741-2020-0514
Niaz Z, Razzaq A, Saleem K, Aziz B, Nazar T, Maqsood U, et al. Atrial fibrillation in mitral stenosis and its correlation with left atrial size, mitral valve area and left atrial thrombus. Biomedica 2005; 21(2): 80-82.
http://doi.org/10.13140/RG.2.2.35106.04809
Seko Y, Kato T, Haruna T, Izumi T, Miyamoto S, Nakane E, et al. Association between atrial fibrillation, atrial enlargement, and left ventricular geometric remodeling. Sci Rep 2018; 8(1): 63-66. https://doi.org/10.1038/s41598-018-24875-1
Boonyasirinant T, Phankinthongkum R, Komoltri C. Clinical and echocardiographic parameters and score for the left atrial thrombus formation prediction in the patient with mitral stenosis. J Med Assoc Thai. 2007;90(2):9-18.
Parameswaran R, Kalman JM. Left atrium and cardiovascular risk: Does functionality matter more than size?. J Am Heart Assoc 2018; 7(7): 89-90.
https://doi.org/10.1161/JAHA.118.008930
Uijl DW, Delgado V, Bertini M, Tops LF, Trines SA, Veire NR, et al. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 2011; 97(22): 1847-1851.
https://doi.org/10.1136/hrt.2010.215335
Dhungana SP, Nepal R, Ghimire R. Prevalence and factors associated with atrial fibrillation among patients with rheumatic heart disease. J Atr Fibrillation 2019; 12(4): 21-43. https://doi.org/10.4022/jafib.2143
Negi PC, Sondhi S, Rana V, Rathoure S, Kumar R, Kolte N, et al. Prevalence, risk determinants and consequences of atrial fibrillation in rheumatic heart disease: 6 years hospital based-Himachal Pradesh- Rheumatic Fever/Rheumatic Heart Disease (HP-RF/RHD) Registry. Indian Heart J. 2018; 70(3): 68-73.
https://doi.org/10.1016/j.ihj.2018.05.013
Pawar P, Mumtaz Z, Phadke M, Bharati A, Mahajan A. Is left atrial fibrosis an independent determinant of atrial fibrillation in mitral stenosis? Indian Heart J 2021; 73(4): 503-505.
https://doi.org/10.1016/j.ihj.2021.06.021
Noubiap JJ, Nyaga UF, Ndoadoumgue AL, Nkeck JR, Ngouo A, Bigna JJ, et al. Meta-analysis of the incidence, prevalence, and correlates of atrial fibrillation in rheumatic heart disease. Glob Heart 2020; 15(1): 38.
https://doi.org/10.5334/gh.807
Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L et al. Temporary removal: expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart rhythm. 2017; 14(10): 275-444.
https://doi.org/10.1016/j.hrthm.2017.05.012
Gerçek M, Börgermann J, Gummert J, Gerçek M. Postoperative atrial fibrillation prediction by left atrial size in coronary artery bypass grafting and five-year survival outcome. J Clin Med 2024; 13(13): 3738.
https://doi.org/10.3390/jcm13133738
Suryabanshi A, Timilsina B, Shakya S, Khanal S, Yadav V, Joshi A, et al. Left atrial enlargement as a predictor of atrial fibrillation in Rheumatic Mitral valve disease: An echocardiography-based retrospective cross-sectional study. J Nepal Health Res Counc. 2024; 21(4): 593-598.
https://doi.org/10.33314/jnhrc.v21i4.4811
Dorasanamma M, Gangaram U, Prasad BI. Correlation of atrial fibrillation and left atrial size in rheumatic mitral valve disease. Int J Adv Med 2021; 8(1): 7.
https://doi.org/10.18203/2349-3933.ijam20205416
Ashmawy MM, El-Gendy EA, Allaithy AM, Zarad AEIA. Clinical and echocardiographic predictor of atrial fibrillation in patient with rheumatic mitral valve disease. Cardiol Angiol 2022; 11(4): 177-184.
https://doi.org/10.9734/ca/2022/v11i430221
Saadeh R, Abu Jaber B, Alzuqaili T, Ghura S, Al-Ajlouny T, Saadeh AM, et al. The relationship of atrial fibrillation with left atrial size in patients with essential hypertension. Scientific Reports 2024; 14(1): 12-50.
https://doi.org/10.1038/s41598-024-51875-1
Arshad M, Pannu FY, Ahmed B, Kamran A, Zafar F, Khalid S, et al. Correlation of atrial fibrillation with left atrial volume in patients with mitral stenosis. A single centre study from Pakistan. Pak J Sur Med. 2020; 1(1): 23-28.
https://doi.org/10.37978/pjsm.v1i1.105
Sabry AM, Mansour HAE, Abo El-Azm TH, Mostafa SA, Zahid BS. Echocardiographic predictors of atrial fibrillation after mitral valve replacement. Egypt Heart J 2017; 69(4): 281-288.
https://doi.org/10.1016/j.ehj.2017.07.002
Fabritz L, Crijns HJGM, Guasch E, Goette A, Häusler KG, Kotecha D, et al. Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. Europace 2021; 23(3): 329-344. https://doi.org/10.1093/europace/euaa279
Heitmann KA, Lochen ML, Stylidis M, Hopstock LA, Schirmer H, Morseth B et al. Associations between physical activity, left atrial size and incident atrial fibrillation: the Tromso Study 1994-2016. Open Heart. 2022; 9.
https://doi.org/10.1136/openhrt-2021-001823
Marcusohn E, Kobo O, Postnikov M, Epstein D, Agmon Y, Gepstein L, et al. Left ventricular systolic dysfunction due to atrial fibrillation: clinical and echocardiographic predictors. Card Fail Rev 2021; 7.
https://doi.org/10.15420/cfr.2021.17
Dakay K, Chang AD, Hemendinger M. Left Atrial Enlargement and Anticoagulation Status in Patients with Acute Ischemic Stroke and Atrial Fibrillation. J Stroke Cerebrovasc Dis 2018; 27(1): 192-197.
Downloads
Published
License
Copyright (c) 2025 Atif Ghafoor Abbasi, Nayyar Arif , Zeeshan Ishaq, Muhammad Nadeem , Syed Sajidain, Saba Kabir Khan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
